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INTRODUCTION 1
Tuberculosis (TB) in children reflects a broad spectrum of disease, ranging from asymptomatic 2 infection through disseminated disease. 1 Although a higher proportion of young children develop 3 disseminated forms of TB (miliary TB and TB meningitis), 2,3 primary childhood TB is typically more 4 benign than adult-type TB. The majority (~75%) of disease is intrathoracic, 4 most commonly isolated 5 mediastinal lymph node, Ghon focus or Ghon complex disease. 5 In mid-childhood, mediastinal lymph 6 7 node disease predominates; adult-type disease with pleural effusions and cavitation typically emerges during adolescence. 4, 6 The confirmation of TB in children is challenging due to the 8 paucibacillary nature of the disease, challenges in specimen collection and the wide observed 9 disease spectrum. In addition to informing clinical care, the use of standard case definitions is 10 important to enable the adequate comparison of children in clinical research, where the yield of 11 diagnostic tests, response to treatment, and the efficacy of new drugs or regimen and vaccines are 12 13 evaluated. National Institute of Health (NIH) International Consensus Case Definitions for diagnostic research in childhood TB were proposed in 2012 by an expert panel. 7 These have not yet been 14 applied to contact investigations. 15
The yield of diagnostic tests may correlate with disease spectrum and severity. For example, the 16 yield of mycobacterial culture is considerably higher in children with extensive intrathoracic 17 compared to limited disease. 8 We recently proposed a novel standard approach to describe the 18 spectrum and severity of TB in children 5 which considers both the extent (containment) of disease 19 and the presence of complications; resulting in a final assignation of "severe" or "nonsevere" 20 disease, applicable to both intrathoracic and extrathoracic TB. 5 
21
The NIH case definition focuses on young children <10 years of age presenting with symptoms of 22 intrathoracic TB, typically at the hospital or referral level (Table 1) , and was thus expected to have 23 limited applicability to active TB surveillance studies such as household contact tracing. 24
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Prior to the publication of the NIH definition, we developed standard case definitions for use in a 25 community-based household contact tracing study. We applied and compare the NIH and the 26 protocol case definitions and describe the TB disease spectrum and severity 5 in our prospective 27 community-based study . We hypothesized that our protocol case definition would better apply to 28 our cohort, with anticipated limited disease spectrum and detected through active surveillance. 29 30 31 to blood volumes. Children on isoniazid preventive therapy (IPT) were not excluded. Enrolment was 48 deferred if a Mantoux tuberculin skin test (TST) had been placed within 12 weeks, live attenuated 49 vaccination had been given within 6 weeks, or if there was an acute severe respiratory, diarrheal or 50 neurologic illness. 51 52 A three-pronged approach was employed, recruiting children via either community TB clinics as 53 household contacts of adult TB cases (who started treatment within preceding 3 months; i.e from 54 Page 5 of 29 4 "TB households"), or from neighbouring households ("community controls") or from community 55 paediatric HIV clinics (HIV-infected children with and without documented M.tb exposure). 56 57 All symptomatic adult household members were screened for TB and if diagnosed with TB, that 58 household was reclassified. Children were investigated at enrolment and follow-up for M.tb 59 infection and disease, using standard protocols. 10,11 60 61
Study measures 62
Using methods previously described, 12 the larger study enrolled 1093 children with median follow-63 up duration of 15 months. 13 Children were seen at baseline (enrolment), months 3, 6, 15, and in the 64 case of HIV-infected children, 27 months' follow-up. From the total enrolled, a dataset was compiled 65 of all potential TB cases, detected at any (scheduled and unscheduled) study visits. 66
Children were included in analysis of potential TB cases if they were documented as having 67
Confirmed, Probable or Possible TB (protocol definition), reported by the study team, parent or 68 healthcare provider (TB clinic or referral hospital), or if there was laboratory evidence of M.tb, at any 69 time during the study period. Data sources included the study database, clinic, hospital, and routine 70 laboratory surveillance data. 71
Standard methods were used to define TB symptoms, 11 M.tb contact history, chest radiograph 72 interpretation 14 and bacteriology. TB disease spectrum and severity were described; 5 the most 73 severe manifestation was reported. 74
HIV testing was completed on all children with unknown or negative status (Abbott Determine HIV-75 1/2 rapid test followed by DNA PCR or HIV ELISA depending on whether they were younger or older 76 than 18 months, respectively, in the case of a positive or indeterminate test). All HIV-infected 77 children had access to combination anti-retroviral therapy (cART). 78
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TB exposure history was captured using information including the presence of contact with a known 79 adult (> 18 years old) household or other TB source case (person currently receiving TB treatment 80 regardless of sputum smear status or disease type), the level of exposure and the number of TB 81 cases in the household. The level of exposure was reported as a contact score of 1-10 derived from 82 combined data assuming that the level of exposure was a product of proximity, duration and 83 infectivity of exposure. 12 (Oxford Immunotec, UK) 15 and the Quantiferon-TB Gold In Tube (QTF-IT, Cellestis, Australia) 16 were 91 completed at all study visits.. 17 IGRA results were reported at the visit closest to the TB episode as 92 positive (if either QTF or T-SPOT.TB was positive), negative (both tests negative or only 1 available 93 result, which was negative), indeterminate or not done. M.tb infection was defined as either a 94 positive TST and/or IGRA. 95 96 TB symptoms and signs were classified at the time of the TB episode (Table 1) . 7,11,13,18,19 97 98 Bacteriological data included specimen type, number of specimens sent, number of positive 99 specimens, result of direct smear microscopy for acid-fast-bacilli (AFB), liquid mycobacterial culture 100 (mycobacterial growth indicator tubes; MGIT, Becton Dickinson, Sparks, MD, USA), 20-28 histology, 101 speciation and drug susceptibility test (DST) pattern using the Genotype® MTBDRplus line probe 102 assay (Hain Lifescience, Nehren, Germany). 29 Gastric aspirates were collected in all children younger 103 than 5 years 13 and expectorated sputum samples in all older children at baseline and at subsequent 104 Page 7 of 29 6 scheduled or unscheduled study visits where clinically indicated (e.g. new TB symptoms, new 105 reported TB contact, or previous reported abnormality). 13 Samples were collected, transported and 106 processed following standard guidelines and standard cross-contamination prevention measures 107 were taken. 30 PCR identification of M.tb on any culture-positive specimen defined bacteriological 108 confirmation, while caseating necrosis/granulomas with or without positive microscopy for AFB on 109 cytology or histology specimens defined histological confirmation. 110
Radiological data included all available chest radiograph (CXR) reports. Antero-posterior and lateral 111 CXR were done at all initial visits and at subsequent study visits as clinically indicated. CXRs were 112 reviewed by two experienced independent blinded reviewers using a standard classification. 14 113 Where discrepancies arose, a third blinded, independent reviewer was used. Reviewers reported 114
CXRs as being "Certain TB," "Uncertain TB", "Not TB" or "Normal". A final radiological classification 115 was assigned as either "Compatible with TB," "Abnormal but not compatible with TB" or "Normal". 116
In the case of an abnormal CXR deemed not to be compatible with TB, an alternative clinical 117 diagnosis, where possible, was assigned. 118
119

TB disease definitions 120
The NIH consensus definition 7 and protocol case definition were used ( USA and the Charite Institute, Berlin, Germany and local health authorities. All well children with 131 M.tb contact or positive TST who were HIV-infected or below 5 years of age were referred for IPT, as 132 per local and international guidelines. 31, 32 All cases of suspected TB were referred for treatment. 133
Data management and analysis 134
Agreement between diagnostic approaches was measured using the Kappa statistic with 95% confidence 135 intervals (CI). All cases with a potential TB diagnosis in our cohort were included in analysis, regardless of 136 age. Odds ratios (OR), calculated with Chi-squared or Fisher's exact tests, were used to compare disease 137 severity in HIV-infected vs. uninfected children and in different age and TB exposure groups. The TB disease 138 spectrum was described. TB incidence rates were calculated by age, HIV and TB exposure status. Based on NIH case definitions, 7 there were 8 episodes of confirmed (Table 3) Using the protocol case definition and excluding the episodes classified as "not TB," and "unlikely TB," there 167 were 62 episodes (72%) of nonsevere and 24 episodes (28%) of severe disease. Of those with severe disease, 168 all had intrathoracic disease, 2 (6%) had cavities/adult-type disease, 4 (13%) had expansile pneumonia; and 1 169 (4%) had disseminated disease (miliary TB) [ Table 4 ]. HIV-infected children were more likely to have severe 170 disease than HIV-uninfected children (OR: 3.87; 95% CI 1.26; 11.81, p=0.0056) Children with a documented 171 TB source case were less likely to have severe disease than those without known exposure (21% vs. 44%; OR: This is the first published application of the NIH diagnostic definition for intrathoracic childhood TB, published in 2012. 7 In our community-based diagnostic study, we found that almost two-thirds of 187 children could not be classified using this definition, despite the presence of severe disease in almost 188 a third. In contrast, almost all children could be classified using the protocol case definition, which 189 did not rely on the presence of presenting symptoms. 190 This is most likely explained by the emphasis in the NIH approach on diagnosing TB in symptomatic 191 children, not typically seen in contact investigation studies, where the majority of diseased children 192 are expected to have limited disease and thus more limited symptomatology. The NIH approach 193 would thus have limited applicability to paediatric TB studies using active surveillance, e.g. TB 194 contact investigation, and vaccine trials. 33 We propose the use of our protocol definition as more 195 relevant to contact investigation studies. 196
There was, understandably, poor agreement between the case definitions. Despite the fact that the 197 protocol case definition did not consider tests of TB infection, almost all children were classifiable 198 using well quantified M.tb exposure as a proxy for tests of infection. Well quantified exposure was 199 200 previously shown to correlate well with tests of infection and suggested as a possible replacement for tests of infection in resource-poor settings to guide targeted IPT delivery. 12 A major difference 201 resulting from the use of the NIH and protocol case definitions lies in the number of confirmed 202 cases detected (Table 3 ). Using the protocol definition, there were almost threefold the number of 203 204 confirmed cases than with the NIH definition. Only 8 of these 23 cases (with at least bacteriological confirmation) had "well-defined symptoms" 18 , although most had symptoms of more acute 205 duration with or without abnormal CXR. We agree that all 23 children may not have had overt 206 disease, however, all were treated as TB by the program. Recent well-documented M.tb exposure 207 with isolated bacteriological confirmation may be described as "acute TB infection" as supported by 208 natural history studies, where positive mycobacterial cultures were obtained in children with 209 Page 12 of 29 normal chest radiographs and a positive TST or history of M.tb exposure. 4 We appreciate that whilst 210 the clinical relevance in children with bacteriological confirmation without well-defined TB 211 symptoms remains unknown and an area of ongoing discussion, it is not imprudent to regard such 212 cases with high suspicion due to the risk of dissemination in very young or HIV-infected children, 213
given that laboratory contamination can be excluded. Management should be on a case-by-case 214 basis until consensus is reached. 215
The site of TB disease seen in our cohort was almost exclusively intrathoracic, but with a wide 216 observed disease spectrum and severity, ranging from uncomplicated intrathoracic lymph node 217 disease to uncontrolled intrathoracic disease with complications (lymph node or other) [ Table 4 ]. 218
Despite this being a predominantly (62%) asymptomatic (i.e. no "well-defined" symptoms 18 ) cohort 219 of children recruited through active surveillance, 28% of children had severe intrathoracic disease. 220
HIV-infected children had the highest proportion of severe disease (48%), followed by children 221 without documented TB source exposure (44%). Possible explanations for the unexpectedly high 222 rate of severe disease are the high HIV prevalence and the high proportion of young children in our 223 study ( Table 2) , both risk factors for severe disease. 2, 3, 34, 35 HIV infection is associated with a higher 224 incidence of severe intrathoracic disease including cavities 34 although not more disseminated 225 disease. 34 HIV-infected children recently started on cART may however be prone to more severe 226 disease manifestations including TB Immune Reconstitution Inflammatory Syndrome (IRIS). 36 High TB 227 incidence rates have been reported in HIV-infected children 37, 38 despite the availability of IPT and 228 improved immunological function on cART, 39 consistent with our findings. 229
Diagnostic and treatment delay in adults 40 may also have led to delayed presentation of children 230 resulting in disease progression, especially in children without known TB exposure, where TB may 231 not have been readily suspected in the absence of a known source case. 41 Lastly, poor IPT uptake 232 may be reflected in the high TB rates seen here in HIV-infected and -uninfected under-five year olds, 233 despite IPT recommendations. Although IPT would not have prevented the majority of our TB cases, 234 Page 13 of 29
CONCLUSIONS 241
The current NIH case definition for paediatric intrathoracic TB has limited applicability to household 242 contact studies where, as shown in this study from a high-TB burden setting, a surprisingly wide 243 spectrum of TB disease was observed in HIV-infected and uninfected children. Further work is 244 needed to develop paediatric TB case definitions to ensure that the wide spectrum of relevant 245 paediatric TB observed in clinical research is captured, including in contact investigation studies. 246 
